Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pigment Cell Melanoma Res ; 26(2): 259-62, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23167872

ABSTRACT

A French and an Australian study have recently identified a rare germline functional variant in the microphthalmia-associated transcription factor (MITF) (E318K) that predisposes to familial and sporadic melanoma and to renal cell carcinoma (RCC), showing a new link between two tumour types with different risk factors and between deregulated sumoylation and cancer. The aim of this study was to test the prevalence of the MITF E318K mutation in 667 Italian melanoma patients. We observed significant associations between histological subtypes and family cancer history. Carriers exhibited a nearly threefold higher risk of developing melanoma compared with controls. Carriers were also more likely to have developed multiple primary melanomas (6.40-fold), compared with wt patients. Carriers with a personal and/or family history of pancreatic cancer and kidney cancer had a nearly 31- and eightfold higher risk of developing melanoma compared with wt patients. Our findings further support MITF as a medium-penetrance melanoma susceptibility gene, highlight a potential association with histological subtypes and suggest that MITF may predispose to pancreatic cancer.


Subject(s)
Amino Acid Substitution/genetics , Genetic Predisposition to Disease , Germ-Line Mutation/genetics , Melanoma/genetics , Melanoma/pathology , Microphthalmia-Associated Transcription Factor/genetics , Skin Neoplasms/genetics , Case-Control Studies , Family , Female , Humans , Italy , Male , Pedigree , Prevalence , Skin Neoplasms/pathology
2.
Am J Hum Genet ; 71(6): 1395-412, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12454801

ABSTRACT

Hereditary nonpolyposis colorectal cancer (HNPCC) is caused by mutations in the mismatch-repair genes. We report here the identification and characterization of a founder mutation in MSH2 in the Ashkenazi Jewish population. We identified a nucleotide substitution, MSH2*1906G-->C, which results in a substitution of proline for alanine at codon 636 in the MSH2 protein. This allele was identified in 15 unrelated Ashkenazi Jewish families with HNPCC, most of which meet the Amsterdam criteria. Genotype analysis of 18 polymorphic loci within and flanking MSH2 suggested a single origin for the mutation. All colorectal cancers tested showed microsatellite instability and absence of MSH2 protein, by immunohistochemical analysis. In an analysis of a population-based incident series of 686 Ashkenazi Jews from Israel who have colorectal cancer, we identified 3 (0.44%) mutation carriers. Persons with a family history of colorectal or endometrial cancer were more likely to carry the mutation than were those without such a family history (P=.042), and those with colorectal cancer who carried the mutation were, on average, younger than affected individuals who did not carry it (P=.033). The mutation was not detected in either 566 unaffected Ashkenazi Jews from Israel or 1,022 control individuals from New York. In hospital-based series, the 1906C allele was identified in 5/463 Ashkenazi Jews with colorectal cancer, in 2/197 with endometrial cancer, and in 0/83 with ovarian cancer. When families identified by family history and in case series are included, 25 apparently unrelated Ashkenazi Jewish families have been found to harbor this mutation. Although this pathogenic mutation is not frequent in the Ashkenazi Jewish population (accounting for 2%-3% of colorectal cancer in those whose age at diagnosis is <60 years), it is highly penetrant and accounts for approximately one-third of HNPCC in Ashkenazi Jewish families that fulfill the Amsterdam criteria.


Subject(s)
Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , DNA-Binding Proteins , Founder Effect , Genetic Predisposition to Disease , Jews/genetics , Point Mutation/genetics , Proto-Oncogene Proteins/genetics , Alanine/genetics , Case-Control Studies , Chromosomes, Human, Pair 2/genetics , Crystallography, X-Ray , Female , Gene Frequency/genetics , Haplotypes/genetics , Heterozygote , Humans , Israel , Male , Microsatellite Repeats/genetics , MutS Homolog 2 Protein , Mutation, Missense/genetics , Neoplasms/genetics , Pedigree , Polymorphism, Genetic/genetics , Proline/genetics , Protein Conformation , Proto-Oncogene Proteins/analysis , Proto-Oncogene Proteins/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...